Toronto, Ontario–(Newsfile Corp. – September 8, 2025) – Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into a binding definitive share exchange agreement dated September…

Toronto, Ontario–(Newsfile Corp. – September 4, 2025) – Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated March 18, 2025 with Monjin Interviews Private…

Toronto, Ontario–(Newsfile Corp. – March 24, 2025) – Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that it has entered into a non-binding letter of intent dated March 18, 2025, (the "LOI")…

Toronto, Ontario–(Newsfile Corp. – July 29, 2024) – Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed the second trance of its previously announced private placement. The Company issued 2,500,000 common shares…

Toronto, Ontario–(Newsfile Corp. – July 8, 2024) – Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed the first trance of its previously announced private placement. The Company issued 2,900,000 common…